Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Black Diamond Therapeutic Q1 EPS $0.98 Beats $0.02 Estimate, Sales $70.00M

Author: Benzinga Newsdesk | May 12, 2025 03:38pm
Black Diamond Therapeutic (NASDAQ:BDTX) reported quarterly earnings of $0.98 per share which beat the analyst consensus estimate of $0.02 by 4800 percent. This is a 380 percent increase over losses of $(0.35) per share from the same period last year. The company reported quarterly sales of $70.00 million which beat the analyst consensus estimate of $17.50 million by 300.00 percent.

Posted In: BDTX


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist